Day: May 25, 2023

ISSAQUAH, Wash., May 25, 2023 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the third quarter (twelve weeks) and the first 36 weeks of fiscal 2023, ended May 7, 2023. Net sales for the quarter increased 1.9 percent, to $52.60 billion, from $51.61 billion last year. Net sales for the first 36 weeks increased 5.5 percent, to $160.28 billion, from $151.97 billion last year. Comparable sales for the third quarter and first 36 weeks of fiscal 2023 were as follows:  12 Weeks   12 Weeks   36 Weeks   36 Weeks      Adjusted*       Adjusted*U.S. -0.1%    1.8%    4.9%    4.7% Canada -1.0%    7.4%    1.6%    8.4% Other International 4.1%    8.4%    1.6%    9.0%                Total Company 0.3%    3.5%    4.0%    5.8%                E-commerce -10.0%    -9.0%    -7.8%    -6.6% *Excluding...

Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the fourth quarter (Q4) and full year of fiscal year 2023 (FY2023), which ended March 31, 2023. 23andMe is the only company with multiple U.S. Food and Drug Administration (FDA) authorizations for over-the-counter genetic health risk reports. The Company has also created the world’s largest, re-contactable crowdsourced platform of genotypic information paired with billions of phenotypic data points contributed...

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2023 financial results. First Quarter Financial Highlights:Total revenue for the three months ended March 31, 2023, was $677,617, an increase of 20% compared to $565,433 in the three months ended March 31, 2022.License and royalty revenue for the three months ended March 31, 2023 was $138,180, an increase of 66% compared to $83,349 in the three months ended March 31, 2022.Revenue from product and services sales for the three months ended March 31, 2023 was $539,437, an increase of 12% from $482,084 in the three...